SEP 30, 2021 3:00 AM PDT

Gut Microbiota Influences Colon Cancer Development

WRITTEN BY: Katie Kokolus

The gut microbiome consists of all the microorganisms living in an individual’s digestive system. Various factors including diet, alcohol and tobacco use, age and physical activity impact the microbiome.

Direct associations between the makeup of the microbiome and cancer are well established.  Further, the response to cancer treatment, particularly immune-based therapies, is impacted by microbiome content.  Indications connecting the microbiome to treatment-related toxicities also exist.  Thus, the microbiome has recently materialized as a popular area of focus in cancer research. 

A new study published in Cell Host & Microbe correlated high levels of specific gut bacteria to greater chances of precancerous colon polyps becoming cancerous.  The study followed 40 patients undergoing routine colon cancer screening colonoscopies. The patients enrolled in the study ranged in age from 50 – 75, and two-thirds were female.  

The researchers took biopsies near the colon polyps and identified the different bacterial colonies present within the tissue.  They performed a similar screen of bacteria in the tissue of polyp-free patients. 

Analysis revealed elevated levels of a particular strain of bacteria, Bacteroides fragilis, in the patients with polyps compared to the polyp-free cohort. 

Further evaluation of the Bacteroides fragilis revealed differences in the gene signatures between patients with polyps and those that were polyp-free.  The research team found enrichment of several genes involved in immune activation and the inflammatory response in the Bacteroides fragilis of patients with polyps. 

The authors conclude that their study shows a prominent role of Bacteroides fragilis in the early stages of cancer development predisposing individuals to polyps.  They further indicate that the microenvironment within a polyp selects strains of bacteria that promote inflammation, further enhancing polyp growth. 

This study provides a new understanding of the mechanisms underlying the microbiome’s ability to induce colorectal cancer.  These findings also indicate that analysis of the microbiome could aid in the development of new diagnostic tools and improved guidelines for determining personalized medicine regimens. 

Sources: microbiomeassociationsCell Host & Microbe

About the Author
  • PhD in Tumor Immunology. I am interested in developing novel strategies to improve the efficacy of immunotherapies used to extend cancer survivorship.
You May Also Like
JUN 07, 2021
Health & Medicine
Higher Incidence of Breast Cancer in Polluted Urban Areas
JUN 07, 2021
Higher Incidence of Breast Cancer in Polluted Urban Areas
A Taiwanese study looked at the incidence of breast cancer in areas of Taiwan with varying levels of air pollutants. Air ...
JUL 23, 2021
Cancer
New Drug Eradicates Breast Cancer Tumors in Days
JUL 23, 2021
New Drug Eradicates Breast Cancer Tumors in Days
A new drug can kill between 95 and 100% of cancer cells in mice with human estrogen-receptor-positive breast cancer. The ...
AUG 12, 2021
Cancer
Promising Drug Target Identified for Deadly Ovarian Cancer
AUG 12, 2021
Promising Drug Target Identified for Deadly Ovarian Cancer
Scientists at the University of Alabama at Birmingham have identified a gene called DOT1L for its role in progressing th ...
AUG 19, 2021
Immunology
Immune Enzyme Kills Viruses but Makes Tumors Stronger
AUG 19, 2021
Immune Enzyme Kills Viruses but Makes Tumors Stronger
Robert Louis Stevenson’s 1886 novel Strange Case of Dr. Jekyll and Mr. Hyde describes a man who is a kind, respect ...
AUG 26, 2021
Cancer
COVID-19 Vaccination Induces Strong Immunity in Cancer Patients
AUG 26, 2021
COVID-19 Vaccination Induces Strong Immunity in Cancer Patients
Cancer patients have a higher risk of developing severe symptoms from a COVID-19 infection.   Many cancer pati ...
SEP 16, 2021
Technology
Scientists Create Tiny Replicas Of The Pancreas To Study New Drugs
SEP 16, 2021
Scientists Create Tiny Replicas Of The Pancreas To Study New Drugs
Pancreatic cancer it’s often hard to diagnose in its early stages, resulting in patients having more advanced canc ...
Loading Comments...